Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Symbio Pharmaceuticals (4582 JP)
Watchlist
32
Analysis
Health Care
•
Japan
Symbio Pharmaceuticals Limited develops and commercializes prescription drugs n oncology, hematology and auto-immune disease for Japan and other Asia Pacific markets.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Symbio Pharmaceuticals
•
21 Feb 2020 22:30
•
Issuer-paid
SymBio Pharmaceuticals - Supply issues continue
SymBio reported sales of $25.8m (¥2.838bn) for 2019 and an operating loss of $39.1 (¥4.301bn). Sales were down from 2018 due to the previously...
Edison Investment Research
Follow
588 Views
Share
bullish
•
Symbio Pharmaceuticals
•
21 Feb 2020 16:46
•
Issuer-paid
SymBio Pharmaceuticals - Supply issues continue
SymBio reported sales of ¥2.838bn for 2019 and an operating loss of ¥4.301bn. Sales were down from 2018 due to the previously announced quality...
Edison Investment Research
Follow
591 Views
Share
bullish
•
Symbio Pharmaceuticals
•
05 Dec 2019 23:38
•
Issuer-paid
SymBio Pharmaceuticals - Treakisym has positive DLBCL results
On 5 November 2019, SymBio announced it obtained positive results in its pivotal Phase III clinical trial of Treakisym (bendamustine) in patients...
Edison Investment Research
Follow
1.6k Views
Share
bullish
•
Symbio Pharmaceuticals
•
05 Dec 2019 17:02
•
Issuer-paid
SymBio Pharmaceuticals - Treakisym has positive DLBCL results
On 5 November 2019, SymBio announced it obtained positive results in its pivotal Phase III clinical trial of Treakisym (bendamustine) in patients...
Edison Investment Research
Follow
1.6k Views
Share
bullish
•
Thematic (Sector/Industry)
•
28 Dec 2018 17:53
Japan Pharma - Top Picks (28 Dec 2018)
...
Dion Stéfan Büchner M.D., FCAP
890 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x